The surrounding pulmonary parenchyma is characteristically although variably abnormal. In the earlier literature, based primarily on post-mortem studies, acute and chronic pneumonitis was usually ...

In COPD, the lung may express even greater variability, since the airways may be affected even more than the parenchyma. Emphysema is patchy at the same time, while the airways and local areas in ...

The discovery of a lung-specific autoantigen, the loss of tolerance to which can result in autoimmune-mediated lung disease, has provided an explanation for the common pulmonary complications of ...

In working toward identifying the diagnosis that is most likely to explain the patient’s persistent parenchymal pulmonary opacity, I will begin by considering atypical presentations of two ...

[56,57] Arrows with brackets indicate data from nonquantitative approaches. ‡ Comparison of idiopathic pulmonary fibrosis versus sarcoidosis and systemic sclerosis (↑: upregulated in ...

The UAB ILD Center offers clinical trial enrollment for patients with idiopathic pulmonary fibrosis and other forms of diffuse parenchymal lung disease as part of a multidisciplinary and integrated ...

The researchers hope their discoveries will lead to novel strategies to not just slow fibrosis but promote functional repair ...